High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancerEva Philipson(Sahlgrenska University Hospital), Johan Bourghardt Fagman(University of Gothenburg)BMC CancerMarch 30, 202210.1186/s12885-022-09468-6Cited by 13SaveCiteExport RISWatch citationsRelated PapersEGFR, but not COX‑2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival|Oncology Letters|2019|12